Product Description: MBP146-78 is a potent and selective inhibitor of cGMP dependent protein kinases.
Applications: COVID-19-immunoregulation
Formula: C21H22FN3
References: [1]Nare B, et al. Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy. Antimicrob Agents Chemother. 2002 Feb;46(2):300-7.
CAS Number: 188343-77-3
Molecular Weight: 335.42
Compound Purity: 99.87
Research Area: Infection
Solubility: DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)